Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)
:INDRAMEDCO
Want to see IN:INDRAMEDCO full AI Analyst Report?
Top Page
Indraprastha Medical Corporation Limited
(INDRAMEDCO)
Select Model
Select Model
Rating:71Outperform
Price Target:
₹419.00
▼(-8.12% Downside)
Action:Upgraded
Date:05/15/26
The score is driven primarily by strong fundamentals—material margin expansion, low leverage, and improving cash generation—partly offset by weak technical positioning (trading below major moving averages). Valuation appears reasonable with a modest dividend yield, providing some support but not enough to outweigh the current technical softness.
Positive Factors
Profitability Recovery
A sustained increase in EBIT and net margins over multiple years signals durable operating improvements: better pricing, mix, and cost control. This strengthens internal funding for reinvestment, supports higher returns on equity and provides buffer against cyclical revenue volatility over the next 2–6 months.
Negative Factors
Slowing Revenue Growth
Decelerating top-line growth reduces the company’s ability to scale fixed-cost leverage and may force reliance on margin improvements for earnings growth. Over 2–6 months this can limit reinvestment scope and make outcomes more sensitive to volume or pricing swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
A sustained increase in EBIT and net margins over multiple years signals durable operating improvements: better pricing, mix, and cost control. This strengthens internal funding for reinvestment, supports higher returns on equity and provides buffer against cyclical revenue volatility over the next 2–6 months.
Read all positive factors
Indraprastha Medical Corporation Limited (INDRAMEDCO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹36.36B
Dividend Yield0.96%
Average Volume (3M)33.92K
Price to Earnings (P/E)19.7
Beta (1Y)1.52
Revenue Growth9.30%
EPS Growth14.06%
CountryIN
Employees2,977
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)19.06
Shares Outstanding91,673,000
10 Day Avg. Volume18,340
30 Day Avg. Volume33,918
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)4.61
Price to Sales (P/S)2.30
P/FCF Ratio26.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.5
Revenue Forecast (FY)₹15.98B
Indraprastha Medical Corporation Limited Business Overview & Revenue Model
Company Description
Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive rang...
How the Company Makes Money
INDRAMEDCO makes money mainly through hospital operations and related patient-care services. Key revenue streams typically include: (1) Inpatient services: room/bed charges, nursing care, ICU/critical care, procedure and operating theatre charges,...
Indraprastha Medical Corporation Limited Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
79
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.05B | 14.83B | 13.56B | 12.45B | 10.99B | 8.88B |
| Gross Profit | 3.81B | 5.06B | 3.50B | 3.13B | 6.25B | 4.79B |
| EBITDA | 2.78B | 2.67B | 2.44B | 2.07B | 1.61B | 1.17B |
| Net Income | 1.75B | 1.84B | 1.61B | 1.24B | 861.50M | 586.20M |
Balance Sheet | ||||||
| Total Assets | 9.54B | 9.91B | 8.52B | 7.23B | 5.55B | 4.62B |
| Cash, Cash Equivalents and Short-Term Investments | 4.61B | 2.74B | 3.19B | 2.24B | 1.36B | 660.10M |
| Total Debt | 313.40M | 368.60M | 327.60M | 339.50M | 24.80M | 53.10M |
| Total Liabilities | 2.96B | 2.51B | 2.55B | 2.45B | 1.76B | 1.36B |
| Stockholders Equity | 6.58B | 7.40B | 5.97B | 4.78B | 3.79B | 3.25B |
Cash Flow | ||||||
| Free Cash Flow | 808.10M | 1.30B | 1.20B | 1.31B | 998.90M | 418.10M |
| Operating Cash Flow | 935.10M | 1.89B | 1.57B | 2.00B | 1.44B | 712.90M |
| Investing Cash Flow | -1.47B | -2.02B | -1.11B | -1.58B | -1.08B | -511.00M |
| Financing Cash Flow | -56.60M | -434.60M | -458.80M | -323.80M | -260.40M | -33.70M |
Indraprastha Medical Corporation Limited Technical Analysis
Neutral
456.05
Price Trends
395.10
Negative
395.80
Negative
444.16
Negative
Market Momentum
-0.33
Negative
54.41
Neutral
58.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDRAMEDCO, the sentiment is Neutral. The current price of 456.05 is above the 20-day moving average (MA) of 386.13, above the 50-day MA of 395.10, and above the 200-day MA of 444.16, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 54.41 is Neutral, neither overbought nor oversold. The STOCH value of 58.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:INDRAMEDCO.
Indraprastha Medical Corporation Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹36.36B | 19.73 | ― | 0.96% | 9.30% | 14.06% | |
67 Neutral | ₹1.22T | 62.85 | ― | 0.27% | 15.76% | 34.29% | |
67 Neutral | ₹736.31B | 70.44 | ― | 0.11% | 17.28% | 34.55% | |
66 Neutral | ₹346.44B | 62.91 | ― | 0.04% | 19.44% | 15.55% | |
65 Neutral | ₹42.52B | 38.03 | ― | 0.16% | 15.40% | 19.65% | |
61 Neutral | ₹1.06T | 72.69 | ― | 0.14% | 19.14% | 34.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
394.60
-0.17
-0.04%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,487.65
1,501.88
21.50%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
266.20
11.90
4.68%
IN:FORTIS
Fortis Healthcare Ltd.
971.40
206.85
27.06%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,078.00
-118.12
-9.88%
IN:MEDANTA
Global Health Limited
1,303.95
175.86
15.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.